| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $29.4M | +161.5% |
| SG&A Expense | $12.2M | +20.2% |
| Operating Income | -$41.7M | -94.4% |
| Interest Expense | $1.3M | — |
| Pre-tax Income | -$42.1M | -96.2% |
| Income Tax | -$1.2M | +73.5% |
| Net Income | -$40.9M | -141.5% |
| EPS (Basic) | -$1.43 | -116.7% |
| EPS (Diluted) | -$1.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.8M | +13.1% |
| Current Assets | $76.5M | +14.4% |
| Total Assets | $77.0M | +14.6% |
| Current Liabilities | $9.8M | +161.5% |
| Total Liabilities | $33.0M | +727.7% |
| Stockholders' Equity | $44.0M | -30.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.7M | -105.9% |
| Financing Cash Flow | $34.3M | -29.9% |
| -116.7% |